From: Pregnancy in the FONTAN palliation: physiology, management and new insights from bioengineering
Maternal complications | Overall prevalence (%) | Range (%) |
---|---|---|
Arrhythmias | ||
āSVT | 8.4% | 3ā37% |
āHeart failure | 3.9% | 3ā11% |
āThromboembolism | Ā | Ā |
Obstetric complications | ||
āAnte-partum | 11% | 23% |
āPost-partum | 43% | Ā |
āMajor haemorrhage | 14% | Ā |
Foetal complications | ||
āMiscarriages | Ā | 27ā69% |
āPrematurity | Ā | 70ā80% |
āSGA | 60% | Ā |
āIUGR | 70% | Ā |
āNND | 5% | Ā |
āPROM | Ā | 10ā20% |